Home › Research › Risk factors
Dissecting the Interactions of Diabetes Mellitus and Hearing Loss with Cognitive Decline and Dementia
Sofia Waissbluth, Paul Hinckley Delano. Brain Sciences, 2025-06-21
Topic: Risk, prevention and care in population studies
Plain-language summary
The aging population is increasingly affected by both diabetes mellitus and hearing loss, two conditions that often coexist and can significantly impact quality of life. As the prevalence of diabetes rises with age, so does the incidence of hearing impairment, with both conditions contributing to cognitive decline and functional limitations. The interplay between diabetes, hearing loss, and cognition highlights the need for comprehensive healthcare strategies that address the unique challenges faced by older adults. This review explores the mechanisms underlying the interplay between these three conditions, including mitochondrial dysfunction, neuroinflammation, oxidative stress, and microangiopathy.
What this study adds
Evidence grade: Low
This review discusses how diabetes and hearing loss may coexist and contribute to cognitive decline, exploring mechanisms such as mitochondrial dysfunction, neuroinflammation, oxidative stress and microangiopathy. It presents no new treatment or prevention trial results and does not test whether treating either condition reduces dementia risk.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Waissbluth, S., & Delano, P. H. (2025). Dissecting the Interactions of Diabetes Mellitus and Hearing Loss with Cognitive Decline and Dementia. Brain Sciences. https://doi.org/10.3390/brainsci15070669
Vancouver
Waissbluth S, Delano PH. Dissecting the Interactions of Diabetes Mellitus and Hearing Loss with Cognitive Decline and Dementia. Brain Sciences. 2025. doi:10.3390/brainsci15070669. PMID: 40722262.
BibTeX
@article{waissbluth2025-40722262,
author = {Waissbluth, Sofia and Delano, Paul Hinckley},
title = {{Dissecting the Interactions of Diabetes Mellitus and Hearing Loss with Cognitive Decline and Dementia}},
journal = {Brain Sciences},
year = {2025},
doi = {10.3390/brainsci15070669},
pmid = {40722262},
url = {https://doi.org/10.3390/brainsci15070669}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The aging population is increasingly affected by both diabetes mellitus and hearing loss, two conditions that often coexist and can significantly impact quality of life.
Why it matters
This review discusses how diabetes and hearing loss may coexist and contribute to cognitive decline, exploring mechanisms such as mitochondrial dysfunction, neuroinflammation, oxidative stress and microangiopathy. It presents no new treatment or prevention trial results and does not test whether treating either condition reduces dementia risk.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Brain Sciences) |
| Journal's citation record | 1 / 4 | Brain Sciences: journal h-index 115 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Paul Hinckley Delano: h-index 20 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Chile: institution h-index 541 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40722262) |
| Free to read | 2 / 2 | Free to read |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Related studies in Risk factors from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.